Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Glaukos Corp    GKOS

GLAUKOS CORP (GKOS)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 06/21 05:44:24 pm
40.025 USD   -10.08%
05/30GLAUKOS : Announces Participation in William Blair Growth Stock Conf..
BU
05/16GLAUKOS CORPORA : GKOS) Files An 8-K Regulation FD Disclosure
AQ
05/10GLAUKOS : 1Q Earnings Snapshot
AQ
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/15/2018 06/18/2018 06/19/2018 06/20/2018 06/21/2018 Date
43.02(c) 43.83(c) 43.44(c) 44.51(c) 39.99 Last
416 739 376 343 537 783 389 190 525 510 Volume
-1.76% +1.88% -0.89% +2.46% -10.16% Change
More quotes
Financials (USD)
Sales 2018 164 M
EBIT 2018 -13,6 M
Net income 2018 -11,9 M
Finance 2018 33,0 M
Yield 2018 -
Sales 2019 187 M
EBIT 2019 -4,03 M
Net income 2019 -2,72 M
Finance 2019 41,0 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 9,07x
EV / Sales2019 7,90x
Capitalization 1 516 M
More Financials
Company
Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma.Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by... 
More about the company
Surperformance© ratings of Glaukos Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAUKOS CORP
06/05GLAUKOS CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/30GLAUKOS : Announces Participation in William Blair Growth Stock Conference
BU
05/16GLAUKOS CORPORATION (NYSE : GKOS) Files An 8-K Regulation FD Disclosure
AQ
05/15GLAUKOS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
05/10GLAUKOS : 1Q Earnings Snapshot
AQ
05/09GLAUKOS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/09GLAUKOS CORP : Results of Operations and Financial Condition, Financial Statemen..
AQ
05/09GLAUKOS CORPORATION : Announces First Quarter 2018 Financial Results
BU
05/02GLAUKOS : Announces Participation in Bank of America Merrill Lynch 2018 Health C..
BU
04/19GLAUKOS CORPORATION : to Release First Quarter 2018 Financial Results after Mark..
BU
More news
Sector news : Medical Devices & Implants
06/15Essilor Calls General Meeting for EssilorLuxottica
DJ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
06/12STRYKER : Approaches Rival Boston Scientific for Deal -- WSJ
DJ
More sector news : Medical Devices & Implants
Latest Tweets
03:19pPremarket analyst action - healthcare
1
12:48p$GKOS downgraded to Neutral from Overweight at JPMorgan. PT $45 
06/17Insider Selling: Glaukos Corp $GKOS COO Sells 8,771 Shares of Stock  
06/12Traders Buy High Volume of Put Options on Glaukos $GKOS  
06/11Get the latest ratings for $GNRT $GKOS $TELL $CATB $CCXI in your inbox with M.. 
More tweets
Qtime:218
News from SeekingAlpha
09:19aPremarket analyst action - healthcare 
05/09Glaukos' (GKOS) CEO Thomas Burns on Q1 2018 Results - Earnings Call Transcrip.. 
05/09Glaukos beats by $0.03, beats on revenue 
05/08Notable earnings after Wednesday?s close 
04/16Glaukos iStent reduces IOP in cataract surgery patients; shares up 3% 
Chart GLAUKOS CORP
Duration : Period :
Glaukos Corp Technical Analysis Chart | GKOS | US3773221029 | 4-Traders
Technical analysis trends GLAUKOS CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 40,7 $
Spread / Average Target -8,5%
EPS Revisions
Managers
NameTitle
Thomas William Burns President, Chief Executive Officer & Director
William J. Link Chairman
Chris M. Calcaterra Chief Operating Officer
Joseph E. Gilliam CFO & Senior VP-Corporate Development
Harold A. Heitzmann Senior VP-Applied Research & Engineering
Sector and Competitors
1st jan.Capitalization (M$)
GLAUKOS CORP73.53%1 516
STRYKER CORPORATION9.62%63 430
SMITH & NEPHEW6.83%15 690
WRIGHT MEDICAL GROUP NV17.84%2 772
JAPAN LIFELINE CO., LTD.10.53%2 135
CERUS CORPORATION114.50%915